FCER1G encodes the gamma chain of the high-affinity IgE receptor, an adapter protein with an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals across multiple immune receptor complexes. In mast cells and basophils, FCER1G is a core component of the IgE receptor and mediates allergic inflammatory signaling 1. FCER1G also associates with interleukin-3 receptors on basophils to promote IL-4 production and T helper 2 cell priming, and pairs with pattern recognition receptors CLEC4D and CLEC4E in myeloid cells to recognize mycobacterial antigens and drive Th1/Th17 responses. Functionally, FCER1G participates in integrin-mediated platelet and neutrophil activation. Beyond classical allergy and innate immunity, FCER1G expression in myeloid and dendritic cell compartments associates with immune cell infiltration in diverse cancer types and inflammatory conditions 2. Recent evidence identifies FCER1G-expressing innate-like T cells with high cytotoxic potential in tumors, where IL-15 signaling drives their expansion and anti-tumor activity 3. FCER1G-associated pathways are enriched in neutrophil activation and NF-κB signaling in acute myocardial infarction 4, and FCER1G functions as a hub gene linking immune dysregulation in non-alcoholic fatty liver disease and heart failure 5. These findings position FCER1G as a nexus between allergic/innate immunity and chr1 inflammatory diseases.